FDA Commissioner Scott Gottlieb will testify Dec. 5 at a Senate health committee oversight hearing on how FDA balances encouraging innovation with protecting public health, the committee announced Thursday (Nov. 15). “Congress has taken a number of steps to help the FDA keep up with the rapid pace of discoveries while continuing to ensure the safety of new drugs and devices,” committee Chair Sen. Lamar Alexander (R-TN) said in a press release. “During this hearing, we will hear from FDA...